Rovi Sees Operating Revenue To Increase By Mid-To High-Single-Digit Percentage Vs 2025
Nov 5 (Reuters) - Laboratorios Farmaceuticos Rovi, S.A. ROVI.MC:
9-MONTH NET PROFIT €162.8 MILLION
9-MONTH OPERATING REVENUE €610.2 MILLION
UPGRADES ITS 2026 OPERATING REVENUE GUIDANCE
NOW EXPECTS OPERATING REVENUE TO INCREASE BY A MID-TO HIGH-SINGLE-DIGIT PERCENTAGE COMPARED WITH 2025
UPGRADE IS MAINLY RESULT OF STRONGER EXPECTED GROWTH OF THE CDMO BUSINESS
WILL PUBLISH ITS 2027 OUTLOOK IN PRESENTATION OF ITS FULL-YEAR 2026 RESULTS, SCHEDULED FOR FEBRUARY 2027
Source text
Further company coverage: ROVI.MC